STAT1-Activating Cytokines Limit Th17 Responses through Both T-bet–Dependent and –Independent Mechanisms
- 1 December 2010
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 185 (11), 6461-6471
- https://doi.org/10.4049/jimmunol.1001343
Abstract
Given the association with autoimmune disease, there is great interest in defining cellular factors that limit overactive or misdirected Th17-type inflammation. Using in vivo and in vitro models, we investigated the molecular mechanisms for cytokine-mediated inhibition of Th17 responses, focusing on the role of STAT1 and T-bet in this process. These studies demonstrate that, during systemic inflammation, STAT1- and T-bet–deficient T cells each exhibit a hyper-Th17 phenotype relative to wild-type controls. However, IL-17 production was greater in the absence of T-bet, and when both STAT1 and T-bet were deleted, there was no further increase, with the double-deficient cells instead behaving more like STAT1-deficient counterparts. Similar trends were observed during in vitro priming, with production of Th17-type cytokines greater in T-bet−/− T cells than in either STAT1−/− or STAT1−/− T-bet−/− counterparts. The ability of IFN-γ and IL-27 to suppress Th17 responses was reduced in T-bet–deficient cells, and most importantly, ectopic T-bet could suppress signature Th17 gene products, including IL-17A, IL-17F, IL-22, and retinoic acid-related orphan receptor γT, even in STAT1-deficient T cells. Taken together, these studies formally establish that, downstream of IFN-γ, IL-27, and likely all STAT1-activating cytokines, there are both STAT1 and T-bet–dependent pathways capable of suppressing Th17 responses.Keywords
This publication has 55 references indexed in Scilit:
- Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune EncephalomyelitisThe Journal of Experimental Medicine, 2004
- Antigen-Specific T Cell Sensitization Is Impaired in IL-17-Deficient Mice, Causing Suppression of Allergic Cellular and Humoral ResponsesImmunity, 2002
- T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cellsNature Immunology, 2002
- The Transcription Factor T-bet Regulates Mucosal T Cell Activation in Experimental Colitis and Crohn's DiseaseThe Journal of Experimental Medicine, 2002
- Distinct Effects of T-bet in T H 1 Lineage Commitment and IFN-γ Production in CD4 and CD8 T CellsScience, 2002
- T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cellsProceedings of the National Academy of Sciences of the United States of America, 2001
- Role of T-bet in Commitment of T H 1 Cells Before IL-12-Dependent SelectionScience, 2001
- Homeostasis-Stimulated Proliferation Drives Naive T Cells to Differentiate Directly into Memory T CellsThe Journal of Experimental Medicine, 2000
- Naive T Cells Transiently Acquire a Memory-like Phenotype during Homeostasis-Driven ProliferationThe Journal of Experimental Medicine, 2000
- A Novel Transcription Factor, T-bet, Directs Th1 Lineage CommitmentCell, 2000